Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study to Assess Objective Endpoint Measurements of Response in Bacterial Skin Infections

ClinicalTrials.gov ID: NCT01283581

Public ClinicalTrials.gov record NCT01283581. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 24, 2026, 11:24 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2 Exploratory Study of Objective Endpoints in Subjects With Acute Bacterial Skin and Skin Structure Infections Treated With Delafloxacin, Vancomycin, or Linezolid

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to compare clinical response to the measurement techniques of several objective measures of clinical efficacy for use in future ABSSSI (Acute Bacterial Skin and Skin Structure Infection) clinical trials

Study identification

NCT ID
NCT01283581
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Melinta Therapeutics, Inc.
Industry
Enrollment
256 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 2011 (Type not available)
Primary completion
Nov 2011 (Actual)
Completion
Nov 2011 (Actual)
Last update posted
Oct 16, 2019

2011

United States locations

U.S. sites
31
U.S. states
16
U.S. cities
30
Facility City State ZIP Site status
University of South Alabama Medical Center Mobile Alabama 36617 —
Drug Research and Analysis Corp Montgomery Alabama 36106 —
Southbay Pharma Research Buena Park California 90620 —
eStudySite Chula Vista California 91911 —
eStudySite La Mesa California 91942 —
HealthCare Partners Medical Group Los Angeles California 90015 —
eStudySite Oceanside California 92056 —
HealthCare Partners Medical Group Pasadena California 91105 —
Christiana Care Health Services Newark Delaware 19713 —
Riverside Clinical Research Edgewater Florida 32132 —
River City Clinical Research Jacksonville Florida 32207 —
Central Florida Internists Kissimmee Florida 34741 —
Central Florida Internists Medical Orlando Florida 32811 —
Central Florida Internists Saint Cloud Florida 34769 —
Ronald Barbour, MD Temple Terrace Florida 33617 —
Southeast Regional Research Group Columbus Georgia 31904 —
Atlanta Institute for Medical Research, Inc Decatur Georgia 30030 —
Southeast Regional Research Group Savannah Georgia 31406 —
University of Kansas Medical Center Kansas City Kansas 66160 —
Four Rivers Clinical Research, Inc Paducah Kentucky 42003 —
Medical Development Centers, LLC Baton Rouge Louisiana 70810 —
University of Missouri Health Care Columbia Missouri 65212 —
Mercury Street Medical Group, PLLC Butte Montana 59701 —
eStudySite Las Vegas Nevada 89109 —
South Jersey Infectious Disease Somers Point New Jersey 08244 —
Montefiore Medical Center The Bronx New York 10467 —
Remington-Davis, Inc. Columbus Ohio 43215 —
Ravi Kamepalli, MD Lima Ohio 45801 —
Health Concepts Rapid City South Dakota 57702 —
Jennifer Johnson-Caldwell, MD Houston Texas 77002 —
Alan Nolasco, MD Houston Texas 77005 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01283581, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 16, 2019 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01283581 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →